Y020-6334 Screening compound: 6-(4-methoxyphenyl)-2-(tetrahydro-2-furanylmethyl)-2,3,4,6-tetrahydro-1H-[1,3,5]triazino[1',2':3,4][1,3,5]triazino[1,2-a][1,3]benzimidazole

Y020-6334 Screening compound: 6-(4-methoxyphenyl)-2-(tetrahydro-2-furanylmethyl)-2,3,4,6-tetrahydro-1H-[1,3,5]triazino[1',2':3,4][1,3,5]triazino[1,2-a][1,3]benzimidazole
Y020-6334 Screening compound: 6-(4-methoxyphenyl)-2-(tetrahydro-2-furanylmethyl)-2,3,4,6-tetrahydro-1H-[1,3,5]triazino[1',2':3,4][1,3,5]triazino[1,2-a][1,3]benzimidazole alternative view

Chemical Structure Depiction of ChemDiv screening compound Y020-6334
6-(4-methoxyphenyl)-2-(tetrahydro-2-furanylmethyl)-2,3,4,6-tetrahydro-1H-[1,3,5]triazino[1',2':3,4][1,3,5]triazino[1,2-a][1,3]benzimidazole

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y020-6334

Molecular Formula

C23H26N6O2 (C23 H26 N6 O2)

Compound Name

6-(4-methoxyphenyl)-2-(tetrahydro-2-furanylmethyl)-2,3,4,6-tetrahydro-1H-[1,3,5]triazino[1',2':3,4][1,3,5]triazino[1,2-a][1,3]benzimidazole

IUPAC name

9-(4-methoxyphenyl)-4-[(oxolan-2-yl)methyl]-24681017-hexaazatetracyclo[8.7.0.0^{27}.0^{1116}]heptadeca-1(17)7111315-pentaene

SMILES

COc1ccc(C2N=C(NCN(CC3OCCC3)C3)N3c3nc(cccc4)c4n23)cc1

InChI

InChI=1S/C23H26N6O2/c1-30-17-10-8-16(9-11-17)21-26-22-24-14-27(13-18-5-4-12-31-18)15-28(22)23-25-19-6-2-3-7-20(19)29(21)23/h2-3,6-11,18,21H,4-5,12-15H2,1H3,(H,24,26)

InChI Key

VWIWPYCZKOWENP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD09430852

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

418.5

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.721

Distribution Coefficient, logD

3.649

Water Solubility, LogSw

-4.00

Polar Surface Area

54.861

Acid Dissociation Constant (pKa)

17.95

Base Dissociation Constant (pKb)

6.66

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

39.10

Y020-6334 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

GPCR Targeted Library (31838 compounds)

Nucleic Acid Ligands (8311 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Infections
  • Cancer
  • Musculoskeletal
  • Nervous system
  • Hemic and lymphatic
  • Immune system
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with Y020-6334 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y020-6334?
Check Price and Availability of Y020-6334, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y020-6334 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y020-6334
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y020-6334
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y020-6334 available by request